Global Metabolomics Market, By Product and Service (Metabolomics Instruments, Bioinformatics Tools and Services), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Others), Indication (Cancer, Cardiovascular Disorders (CVD), Neurological Disorders, Inborn Errors of Metabolism, Others), End User (Pharmaceutical and Biotechnology Companies, Contract research Organizations, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The metabolomics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 6.36 billion by 2028 and is expected grow at a CAGR of 14.29% in the above mentioned forecast period.
Metabolomics is a study, used in the analyzation and classification of metabolites in a sample of DNA of an organism. This study is apprehensive with the identification of the biological systems at a particular amount of time.
The easy availability of government and private funding for metabolomics research is amongst the significant factors expected to fuel the growth and demand of metabolomics market. In addition, the high demand for personalized medicine and rise in the use of metabolomics in toxicology testing are also anticipated to push the growth in the global metabolomics market over the forecast period of 2021 to 2028. Likewise, the high adoption rate of metabolomics as a research and development tool and strong presence of sophisticated healthcare supporting research and development initiatives are also projected to lift the growth of the market. Furthermore, the rise in levels of expenditure in pharmaceutical and biotechnology s is also expected to act as significant factors which will flourish the growth of the metabolomics market.
The increase in the biomarker development, rapid technological advancements, rise in pharmaceutical and biotech R&D expenditure are expected to offer significant growth opportunities for the metabolomics market in the forecast period of 2021 to 2028.
However, the various issues related to data examination and processing and high cost of tools and instruments are estimated to limit the growth of the metabolomics market, whereas, the lack of skilled researchers and complexity and diversity of biological samples can challenge the growth of the metabolomics market.
This metabolomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the metabolomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Metabolomics Market Scope and Market Size
The metabolomics market is segmented on the basis of product and services, application, indication and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- The product and services segment of the metabolomics market is segmented into metabolomics instruments and bioinformatics tools and services. Metabolomics instruments have further been segmented into separation tools and detection tools. Separation tools have further been sub-segmented into gas chromatography, high-performance liquid chromatography, ultra-performance liquid chromatography and capillary electrophoresis. Detection tools have further been sub-segmented into nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS) and surface-based mass analysis. Bioinformatics tools and services have further been segmented into bioinformatics services and bioinformatics tools and databases.
- On the basis of application, the metabolomics market is segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine and others.
- The metabolomics market has also been segmented based on the indication into cancer, cardiovascular disorders (CVD), neurological disorders, inborn errors of metabolism and others.
- On the basis of end user, the metabolomics market is segmented into Academic and Research Institutes, pharmaceutical and biotechnology companies, contract research organizations and others.
Metabolomics Market Country Level Analysis
The metabolomics market is analyzed and market size insights and trends are provided by country, product and services, application, indication and end user as referenced above.
The countries covered in the metabolomics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the metabolomics market owing to the strong presence of high product commercialization rates associated with the presence of sophisticated healthcare supporting research and development initiatives. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the high demand for better pharmaceutical products generated from emerging economies such as India and China.
The country section of the metabolomics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The metabolomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for metabolomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the metabolomics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Metabolomics Market Share Analysis
The metabolomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to metabolomics market.
The major players covered in the metabolomics market report are WATERS, Bruker, TMIC, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., biocrates life sciences ag, Creative Proteomics., PerkinElmer Inc., Metabolon, Inc., Human Metabolome Technologies America Inc., Merck KGaA, Shimadzu Corporation, OWL, Cenix BioScience GmbH, West Coast Metabolomics Center, Stemina Biomarker Discovery, Inc., Chenomx Inc., Bio-Rad Laboratories, Inc., SRI INTERNATIONAL and Eurofins Scientific among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.